Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)

Michael SerriesDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, GermanyCorrespondence[email protected]

Hannah ZenzenDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, Germany

Mario HeineDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, Germany

Tobias HolderriedDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, Germany

Peter BrossartDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, Germany

Katjana SchwabDepartment of Internal Medicine 3, Hematology and Medical Oncology, Centre of Integrated Oncology Aachen-Bonn–Cologne-Duesseldorf, University Hospital of Bonn, Bonn, Germany

Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date